Through a cross-presentation mechanism, both human and mouse cDC1 are capable of capturing extracellular proteins from tumor materials, processing tumor associated antigens (TAA) through class I MHC molecules and presenting to CD8+ T cells that mediate cytotoxicity of tumor cells [72,81,82,83]. This evidence concerns the gene CD8A and neoplasm.